Publications by authors named "Nils Debus"

Claim this Profile
P
Performance of [Ga]Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer after prostatectomy-a multi-centre evaluation of 2533 patients.
Ali Afshar-Oromieh, Marcelo Livorsi da Cunha, Jairo Wagner, Uwe Haberkorn, Nils Debus

Eur J Nucl Med Mol Imaging· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer.
Ali Afshar-Oromieh, Nils Debus, Monika Uhrig, Thomas A Hope, Michael J Evans

Eur J Nucl Med Mol Imaging· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Diagnostic performance of Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.
Ali Afshar-Oromieh, Tim Holland-Letz, Frederik L Giesel, Clemens Kratochwil, Walter Mier, Nils Debus, Jürgen Debus

Eur J Nucl Med Mol Imaging· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance of Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.
Ali Afshar-Oromieh, Tim Holland-Letz, Frederik L Giesel, Clemens Kratochwil, Walter Mier, Nils Debus, Jürgen Debus

Eur J Nucl Med Mol Imaging· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with I-MIP-1095.
Ali Afshar-Oromieh, Uwe Haberkorn, Christian Zechmann, Thomas Armor, Walter Mier, Nils Debus

Eur J Nucl Med Mol Imaging· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follistatin antagonizes transforming growth factor-beta3-induced epithelial-mesenchymal transition in vitro: implications for murine palatal development supported by microarray analysis.
Hendrik Nogai, Mark Rosowski, Joachim Grün, Anika Rietz, Nils Debus

Differentiation· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Binding of human serum amyloid P componentto L-selectin.
Dietger Stibenz, Michael Gräfe, Nils Debus, Michael Hasbach, Inke Bahr

Eur J Immunol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular targeting of lymph nodes with L-selectin ligand-specific US contrast agent: a feasibility study in mice and dogs.
Peter Hauff, Michael Reinhardt, Andreas Briel, Nils Debus, Michael Schirner

Radiology· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel formulation for superparamagnetic iron oxide (SPIO) particles enhancing MR lymphography: comparison of physicochemical properties and the in vivo behaviour.
Kathrin Lind, Mayk Kresse, Nils P Debus, Rainer H Müller

J Drug Target· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis